AcquisitionOther

Indivior Pharmaceuticals, Inc. acquired target

Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

Indivior Pharmaceuticals, Inc. -> target · $1.0 billion

Creates Immediate Scale and Expanded Capabilities · A Diversified Commercial Platform: An 11-product portfolio spans opioid use disorder, psychiatry, and neurology, and includes five core growth drivers – SUBLOCADE®, Qelbree®, GOCOVRI®

Open source record (SEC) ↗

Have a question, or want to talk something through?

Let's Talk